DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q4 2019 holdings

$3.13 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 76 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 51.6% .

 Value Shares↓ Weighting
BuyHORIZON PHARMA INVT LTDnote 2.500% 3/1$191,529,000
+21.1%
144,832,000
+6.5%
6.11%
-5.2%
AHCO NewADAPTHEALTH CORP$188,855,00017,199,888
+100.0%
6.03%
HZNP SellHORIZON THERAPEUTICS PUB LTD$171,672,000
-2.4%
4,742,311
-26.6%
5.48%
-23.7%
MYL BuyMYLAN N V$163,850,000
+8.2%
8,151,754
+6.5%
5.23%
-15.3%
 NEVRO CORPnote 1.750% 6/0$154,250,000
+17.4%
115,776,0000.0%4.92%
-8.1%
ORTX SellORCHARD THERAPEUTICS PLCads$121,856,000
+14.9%
8,862,247
-0.7%
3.89%
-10.0%
FIXX SellHOMOLOGY MEDICINES INC$108,585,000
+4.1%
5,245,638
-8.9%
3.46%
-18.5%
RYTM BuyRHYTHM PHARMACEUTICALS INC$98,482,000
+76.2%
4,289,291
+65.7%
3.14%
+37.9%
MIRM  MIRUM PHARMACEUTICALS INC$84,567,000
+143.7%
3,448,9120.0%2.70%
+90.7%
TNDM BuyTANDEM DIABETES CARE INC$81,150,000
+202.8%
1,361,345
+199.6%
2.59%
+136.9%
XLRN BuyACCELERON PHARMA INC$72,618,000
+40.8%
1,369,625
+4.9%
2.32%
+10.2%
RARX SellRA PHARMACEUTICALS INC$71,320,000
+74.5%
1,519,718
-12.1%
2.28%
+36.6%
CNC BuyCENTENE CORP DEL$69,685,000
+123.6%
1,108,400
+53.9%
2.22%
+74.9%
XENT SellINTERSECT ENT INC$69,646,000
+31.7%
2,797,033
-10.0%
2.22%
+3.1%
 INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$58,256,000
+17.6%
57,791,0000.0%1.86%
-7.9%
MYOK SellMYOKARDIA INC$57,506,000
+12.4%
789,000
-19.6%
1.84%
-12.1%
ARDX BuyARDELYX INC$52,567,000
+228.9%
7,004,253
+106.0%
1.68%
+157.2%
BKD BuyBROOKDALE SR LIVING INC$52,514,000
-3.9%
7,223,419
+0.2%
1.68%
-24.7%
SILK BuySILK ROAD MEDICAL INC$51,665,000
+62.2%
1,279,480
+30.6%
1.65%
+26.9%
DBVT BuyDBV TECHNOLOGIES S Asponsored adr$50,889,000
+84.8%
4,756,000
+48.6%
1.62%
+44.7%
NewDEXCOM INCnote 0.750%12/0$50,441,00034,000,000
+100.0%
1.61%
RCKT BuyROCKET PHARMACEUTICALS INC$49,263,000
+138.4%
2,164,471
+22.0%
1.57%
+86.5%
VCEL BuyVERICEL CORP$47,808,000
+51.7%
2,747,563
+32.0%
1.52%
+18.8%
BPMC BuyBLUEPRINT MEDICINES CORP$45,255,000
+63.3%
564,914
+49.8%
1.44%
+27.8%
ARVN BuyARVINAS INC$44,716,000
+125.2%
1,088,234
+18.1%
1.43%
+76.4%
 CLOVIS ONCOLOGY INCnote 2.500% 9/1$42,905,000
+1.5%
49,064,0000.0%1.37%
-20.5%
AERI SellAERIE PHARMACEUTICALS INC$42,835,000
-51.2%
1,772,255
-61.2%
1.37%
-61.8%
FATE BuyFATE THERAPEUTICS INC$39,191,000
+29.2%
2,002,605
+2.5%
1.25%
+1.1%
SIEN BuySIENTRA INC$37,795,000
+41.0%
4,227,680
+2.2%
1.21%
+10.3%
IMMU SellIMMUNOMEDICS INC$36,451,000
-14.5%
1,722,618
-46.4%
1.16%
-33.1%
ALEC  ALECTOR INC$35,783,000
+19.5%
2,076,8120.0%1.14%
-6.5%
EDIT  EDITAS MEDICINE INC$34,313,000
+30.2%
1,158,8410.0%1.10%
+2.0%
SWTX SellSPRINGWORKS THERAPEUTICS INC$30,339,000
+33.2%
788,243
-25.0%
0.97%
+4.2%
HUM BuyHUMANA INC$30,055,000
+75.5%
82,000
+22.4%
0.96%
+37.4%
BOLD  AUDENTES THERAPEUTICS INC$29,555,000
+113.0%
493,9010.0%0.94%
+66.6%
ARGX SellARGENX SEsponsored adr$29,536,000
-7.8%
184,000
-34.5%
0.94%
-27.9%
 PTC THERAPEUTICS INCnote 3.000% 8/1$28,400,000
+9.6%
24,877,0000.0%0.91%
-14.2%
SRPT SellSAREPTA THERAPEUTICS INC$27,098,000
-5.8%
210,000
-45.0%
0.86%
-26.3%
CNST BuyCONSTELLATION PHARMCETICLS I$25,911,000
+16946.7%
550,000
+2230.5%
0.83%
+13683.3%
FREQ NewFREQUENCY THERAPEUTICS INC$24,869,0001,418,665
+100.0%
0.79%
AVRO BuyAVROBIO INC$23,451,000
+232.2%
1,164,970
+133.0%
0.75%
+159.7%
AXNX NewAXONICS MODULATION TECH INC$23,219,000837,945
+100.0%
0.74%
TPTX SellTURNING POINT THERAPEUTICS I$22,798,000
+56.5%
366,000
-5.6%
0.73%
+22.4%
CABA NewCABALETTA BIO INC$22,750,0001,628,504
+100.0%
0.73%
MRTX SellMIRATI THERAPEUTICS INC$22,422,000
+23.5%
174,000
-25.3%
0.72%
-3.4%
BCRX BuyBIOCRYST PHARMACEUTICALS$21,994,000
+176.7%
6,375,143
+129.8%
0.70%
+116.7%
RETA SellREATA PHARMACEUTICALS INCcl a$20,443,000
+29.2%
100,000
-49.2%
0.65%
+1.1%
MOH SellMOLINA HEALTHCARE INC$20,141,000
-6.8%
148,433
-24.7%
0.64%
-27.0%
GBT SellGLOBAL BLOOD THERAPEUTICS IN$19,952,000
+53.4%
251,000
-6.4%
0.64%
+20.2%
EHTH BuyEHEALTH INC$19,600,000
+166.8%
204,000
+85.5%
0.62%
+108.3%
ADUS SellADDUS HOMECARE CORP$19,241,000
-4.0%
197,915
-21.7%
0.61%
-24.8%
DCPH SellDECIPHERA PHARMACEUTICALS IN$19,170,000
-5.0%
308,000
-48.2%
0.61%
-25.6%
SEM SellSELECT MED HLDGS CORP$18,513,000
-34.8%
793,200
-53.7%
0.59%
-49.0%
XERS BuyXERIS PHARMACEUTICALS INC$18,212,000
-19.7%
2,583,291
+11.9%
0.58%
-37.2%
FTSV SellFORTY SEVEN INC$17,598,000
+265.5%
447,000
-40.4%
0.56%
+186.2%
RVNC NewREVANCE THERAPEUTICS INC$14,607,000900,000
+100.0%
0.47%
KOD NewKODIAK SCIENCES INC$14,390,000200,000
+100.0%
0.46%
MNKKQ SellMALLINCKRODT PUB LTD CO$14,053,000
+39.1%
4,026,750
-3.9%
0.45%
+8.7%
KIDS NewORTHOPEDIATRICS CORP$10,573,000225,000
+100.0%
0.34%
ATRC  ATRICURE INC$9,518,000
+30.3%
292,7770.0%0.30%
+2.0%
SYRS  SYROS PHARMACEUTICALS INC$8,768,000
-33.4%
1,268,9460.0%0.28%
-47.9%
ISEE NewIVERIC BIO INC$8,580,0001,000,000
+100.0%
0.27%
TXMD NewTHERAPEUTICSMD INC COM STK$5,445,0002,250,000
+100.0%
0.17%
STIM BuyNEURONETICS INC$4,827,000
+71.1%
1,075,000
+216.6%
0.15%
+33.9%
XFOR SellX4 PHARMACEUTICALS INC$4,809,000
-32.9%
449,437
-20.3%
0.15%
-47.6%
NewINTERCEPT PHARMACEUTICALS INnote 2.000% 5/1$4,632,0003,500,000
+100.0%
0.15%
ITMR  ITAMAR MED LTDsponsored ads$4,043,000
+47.1%
314,1360.0%0.13%
+15.2%
PBYI NewPUMA BIOTECHNOLOGY INC$3,469,000396,472
+100.0%
0.11%
SWAV NewSHOCKWAVE MED INC$3,074,00070,000
+100.0%
0.10%
INGN SellINOGEN INC$2,529,000
-72.5%
37,016
-80.7%
0.08%
-78.3%
AERI NewAERIE PHARMACEUTICALS INCput$2,509,000103,800
+100.0%
0.08%
ADVM NewADVERUM BIOTECHNOLOGIES INC$2,435,000211,343
+100.0%
0.08%
ALPN SellALPINE IMMUNE SCIENCES INC$956,000
-40.7%
248,992
-38.8%
0.03%
-53.0%
PRTO BuyPROTEON THERAPEUTICS INC$832,000
+161.6%
2,029,000
+65.6%
0.03%
+107.7%
NEOS  NEOS THERAPEUTICS INC$485,000
+2.1%
320,9930.0%0.02%
-21.1%
KMPH SellKEMPHARM INC$196,000
-58.9%
517,692
-25.2%
0.01%
-68.4%
MNLO ExitMENLO THERAPEUTICS INC$0-99,622
-100.0%
-0.02%
EYEN ExitEYENOVIA INC$0-197,069
-100.0%
-0.03%
VRAY ExitVIEWRAY INC$0-378,623
-100.0%
-0.04%
CSTL ExitCASTLE BIOSCIENCES INC$0-92,477
-100.0%
-0.07%
AGRX ExitAGILE THERAPEUTICS INC$0-1,591,652
-100.0%
-0.08%
SYBX ExitSYNLOGIC INC$0-1,107,643
-100.0%
-0.10%
ATEC ExitALPHATEC HOLDINGS INC$0-536,517
-100.0%
-0.11%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-816,096
-100.0%
-0.14%
MOR ExitMORPHOSYS AGsponsored ads$0-124,701
-100.0%
-0.14%
HARP ExitHARPOON THERAPEUTICS INC$0-264,497
-100.0%
-0.15%
IDYA ExitIDEAYA BIOSCIENCES INC$0-422,974
-100.0%
-0.16%
AGLE ExitAEGLEA BIOTHERAPEUTICS INC$0-500,046
-100.0%
-0.16%
ALIM ExitALIMERA SCIENCES INC$0-7,062,607
-100.0%
-0.16%
IGMS ExitIGM BIOSCIENCES INC$0-250,000
-100.0%
-0.18%
ABMD ExitABIOMED INC$0-27,600
-100.0%
-0.20%
PRVB ExitPROVENTION BIO INC$0-725,000
-100.0%
-0.20%
MDCO ExitMEDICINES COput$0-100,000
-100.0%
-0.20%
ExitTELIGENT INC NEWnote 4.750% 5/0$0-9,567,000
-100.0%
-0.23%
BBIO ExitBRIDGEBIO PHARMA INC$0-290,000
-100.0%
-0.25%
AIMT ExitAIMMUNE THERAPEUTICS INC$0-339,480
-100.0%
-0.29%
GH ExitGUARDANT HEALTH INC$0-126,000
-100.0%
-0.33%
KALV ExitKALVISTA PHARMACEUTICALS INC$0-890,668
-100.0%
-0.42%
KNSA ExitKINIKSA PHARMACEUTICALS LTD$0-1,274,086
-100.0%
-0.44%
AVDL ExitAVADEL PHARMACEUTICALS PLCsponsored adr$0-2,722,241
-100.0%
-0.46%
DPLO ExitDIPLOMAT PHARMACY INC$0-2,996,328
-100.0%
-0.60%
ANAB ExitANAPTYSBIO INC$0-425,443
-100.0%
-0.61%
GLPG ExitGALAPAGOS NVspon adr$0-101,010
-100.0%
-0.63%
PTCT ExitPTC THERAPEUTICS INC$0-471,000
-100.0%
-0.65%
ExitWRIGHT MED GROUP N Vnote 2.250%11/1$0-13,625,000
-100.0%
-0.65%
WVE ExitWAVE LIFE SCIENCES LTD$0-807,727
-100.0%
-0.68%
AXGN ExitAXOGEN INC$0-1,842,330
-100.0%
-0.94%
DFBHU ExitDFB HEALTHCARE ACQUISTION COunit 01/30/2023$0-2,500,000
-100.0%
-1.05%
CHRS ExitCOHERUS BIOSCIENCES INC$0-1,540,305
-100.0%
-1.27%
ExitKEMPHARM INCnote 5.500% 2/0$0-62,423,000
-100.0%
-1.31%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings